Search

1. An assessment of beneficiary knowledge of Medicare coverage options and the prescription drug benefit

Publication:

Washington, D.C. : AARP Public Policy Institute, c2006

Subject(s):

Choice Behavior
Decision Making
Health Knowledge, Attitudes, Practice
Insurance, Pharmaceutical Services
Medicare Part D
United States

2. Concerns about opioid use in Medicare Part D in the Appalachian region

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, April 2019

Subject(s):

Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Appalachian Region
United States

3. Doors to extra help: boosting enrollment in the Medicare Part D low-income subsidy

Publication:

Washington, D.C. : AARP Public Policy Institute, c2007

Subject(s):

Medicare Part D
Insurance, Pharmaceutical Services
Eligibility Determination
Health Services Accessibility
United States

4. Electronic prescribing of controlled substances among office-based physicians: 2017

Author(s):

Parasrampuria, Sonal, author
Blanco, Martín, author
Barker, Wesley, author

Publication:

Washington, DC : U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology, September 2019

Subject(s):

Controlled Substances
Electronic Prescribing -- statistics & numerical data
Practice Patterns, Physicians' -- statistics & numerical data
Prescription Drug Diversion -- prevention & control
Electronic Health Records
Medicare Part D
United States
United States. Department of Health and Human Services

5. How do prescription drugs affect the use of other health services?

Author(s):

Wettstein, Gal, author

Publication:

Chestnut Hill, MA : Center for Retirement Research at Boston College, February 2018

Subject(s):

Facilities and Services Utilization
Medicare Part D
Prescription Drugs
United States

6. Opioid overdoses and the limited treatment of opioid use disorder continue to be concerns for Medicare beneficiaries

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

Government Regulation
Medicare Part D
Opiate Overdose
Opioid-Related Disorders
United States

7. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019

Subject(s):

Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

8. Opioid use in Medicare Part D during the onset of the COVID-19 pandemic

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, February 2021

Subject(s):

Analgesics, Opioid
COVID-19
Government Regulation
Medicare Part D
United States
United States. Department of Health and Human Services

9. Opioid use in Medicare Part D in Missouri

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2019

Subject(s):

Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
Missouri
United States

10. Opioid use in Medicare Part D remains concerning

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018

Subject(s):

Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
United States
United States. Department of Health and Human Services